(Q40423477)

English

Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia: Clinical and Economic Outcomes

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia: Clinical and Economic Outcomes (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Rossini F

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Pioltelli P

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Bolis S

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Borin L

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Casaroli I

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Lanzi E

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Maffè P

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Parma M

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Tripputi P

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Pogliani EM

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

425-433

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

The use of aminoglycosides in neutropenic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftriaxone plus Amikacin in Neutropenic Patients: A Report on 100 Cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Re

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infection in cancer patients. A continuing association

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview of empiric antibiotic therapy for the febrile neutropenic patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empirical therapy for bacterial infections in neutropenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylaxis, cost and effectiveness of therapy of infections caused by Gram-positive organisms in neutropenic children

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftriaxone and amikacin as single daily dose in the empiric therapy for febrile episodes in neutropenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized clinical trial of ceftriaxone and teicoplanin versus ceftazidime and teicoplanin as antibiotic therapy in febrile neutropenic cancer patients and bone marrow transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single daily ceftriaxone and tobramycin in the empirical management of febrile neutropenic patients: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic combinations of antibiotics in gram-negative bacillary infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized Comparison of Ceftriaxone versus Cefriaxone plus Amikacin for the Empirical Treatment of Infections in Patients with Altered Host Defense: Microbiological and Clinical Evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current issues in the antibiotic primary management of the febrile neutropenic cancer patient: a perspective from the National Cancer Institute

1 reference

https://pubmed.ncbi.nlm.nih.gov/18370498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-199815050-00007

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

release_a7gk5w5vizbr7pfjhc2m7z2gza

1 reference

https://api.fatcat.wiki/v0/release/a7gk5w5vizbr7pfjhc2m7z2gza

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40423477&oldid=1897350439"